Literature DB >> 9491811

Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach.

J M Swanson1, G A Sunohara, J L Kennedy, R Regino, E Fineberg, T Wigal, M Lerner, L Williams, G J LaHoste, S Wigal.   

Abstract

Previously in this journal, we reported an association of the dopamine D4 receptor gene (DRD4) and attention deficit hyperactivity disorder (ADHD). In a population-association (case-control) study of 39 children with a refined phenotype of ADHD and 39 ethnically matched controls, we observed an increased percentage of the 7 repeat allele (29% vs 12%) and the 7+ genotype (49% vs 21%) in the ADHD group compared to the control group. In a replication and an extension of our initial study, we recruited another sample of ADHD subjects and found percentages of the 7 repeat allele (28%) and the 7+ genotype (48%) consistent with our previous findings. We used a family-based approach to evaluate a predicted association of DRD4 and ADHD based on a test of allele transmission focused on the 7 repeat allele. We identified 52 families based on the diagnosis of the refined phenotype of ADHD in the proband and the availability of DNA from both biological parents as well as the proband. Haplotype relative risk (HRR) analysis was performed to test our a priori hypothesis and produced significant results (chi-square = 4.65, P < 0.035). This provides additional evidence that the DRD4 gene is associated with a refined phenotype of ADHD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491811     DOI: 10.1038/sj.mp.4000354

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  56 in total

1.  Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions.

Authors:  K L Lunetta; S V Faraone; J Biederman; N M Laird
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 2.  Hyperactivity in children: a focus on genetic research and psychological theories.

Authors:  J Kuntsi; J Stevenson
Journal:  Clin Child Fam Psychol Rev       Date:  2000-03

Review 3.  Genes and attention deficit hyperactivity disorder.

Authors:  J Swanson; M Posner; J Fusella; M Wasdell; T Sommer; J Fan
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 4.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

Review 5.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

6.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

7.  The development of executive functioning and theory of mind. A comparison of Chinese and U.S. preschoolers.

Authors:  Mark A Sabbagh; Fen Xu; Stephanie M Carlson; Louis J Moses; Kang Lee
Journal:  Psychol Sci       Date:  2006-01

8.  The Italian preadolescent mental health project (PrISMA): rationale and methods.

Authors:  Alessandra Frigerio; Laura Vanzin; Valentina Pastore; Maria Nobile; Roberto Giorda; Cecilia Marino; Massimo Molteni; Paola Rucci; Massimo Ammaniti; Loredana Lucarelli; Carlo Lenti; Mauro Walder; Andrea Martinuzzi; Ombretta Carlet; Filippo Muratori; Annarita Milone; Alessandro Zuddas; Pina Cavolina; Franco Nardocci; Andrea Tullini; Pierluigi Morosini; Gabriella Polidori; Giovanni De Girolamo
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

9.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.

Authors:  C J Vaidya; G Austin; G Kirkorian; H W Ridlehuber; J E Desmond; G H Glover; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 10.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.